Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

#TCT2021 - Philips Image Guided Therapy System – Azurion

News | Cath Lab

Philips Announces New Innovations and Clinical Data Supporting the Treatment of Patients with Cardiovascular Disease

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

November 10, 2021

News | Cardiac Imaging

Philips to Expand Its Cardiac Diagnostics and Monitoring Portfolio With the Acquisition of Cardiologs

November 10, 2021 — Philips, a global leader in health technology, announced that it has signed an agreement to acquire ...

November 10, 2021

TCT 2021 Announces Late-Breaking Clinical Trials

Feature | TCT

Links to all the TCT 2021 Late-Breaking Clinical Trials

November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021 Transcat ...

November 10, 2021

The Teleflex Manta large bore vascular closure device #TCT2021

News | Vascular Closure Devices

Plug-based Vascular Closure Following TAVR Offers Shorter Hemostasis Time Than Suture-based Devices

November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...

November 09, 2021

Antiplatelet Plavix (Clopidogrel). OPT-PEACE trial found that nearly all patients receiving antiplatelet therapy developed evidence of abnormal gastrointestinal (GI) mucosal findings on capsule endoscopy. GettyImages

News | Antiplatelet and Anticoagulation Therapies

Most PCI Patients on Antiplatelet Therapy Developed Abnormal Gastrointestinal Findings

November 9, 2021 — Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE ...

November 09, 2021

An illustration of the Recor renal denervation ablation balloon at work in the renal artery.. Renal Denervation Recor RDN ablation balloon #TCT2021

News | Hypertension

Renal Denervation Combined With Medication Can Treat Resistant Hypertension

November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound ...

November 09, 2021

$Abbott's fractional flow reserve (FFR) system. #TCT #TCT21 #FAME3$

News | FFR Technologies

FAME 3 Study Finds FFR Guided PCI Did Not Perform as Well at One-year Compared to Bypass Surgery

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

November 09, 2021

The Alvimedica Cre8 Evo Cre8 polymer-free amphilimus-eluting stent

News | Stents

Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents

November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in ...

November 09, 2021

TAVR CT image reconstruction of an implanted Medtronic CoreValve. #TCT21 #TCT #TAVR #SURTAVI

News | Heart Valve Technology

Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement

November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality ...

November 09, 2021

A PARTNER 3 trial economic analysis shows for low surgical risk patients, TAVR is cost-saving compared with SAVR. TAVR Sapien Valve visualized using a GE guidance software. #TCT2021

News | Structural Heart

TAVR Is Cost Effective Compared With Surgical Replacement for Low-risk Patients

November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve ...

November 09, 2021

News | FFR Technologies

QFR Technology for Advanced Coronary Artery Disease Leads to Improved Outcomes

November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...

November 09, 2021

A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes data from of peripheral vascular interventions guided by intravascular ultrasound (IVUS) showed a 32% reduction in major adverse limb events, such as amputations, during lower extremity arterial intervention.

News | Intra-Vascular Ultrasound (IVUS)

IVUS Improved Outcomes in Largest Real-world Analysis of Lower Extremity Peripheral Vascular Interventions

November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes ...

November 09, 2021

The two FDA-cleared transcatheter LAA occlusion devices on the U.S. market were compared in the SWISS-APERO and SEAL FLX trials presented at TCT 2021. Left is the Abbott Amulet device, right is the newest generation Watchman FLX device.

News | Left Atrial Appendage (LAA) Occluders

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage ...

November 08, 2021

The Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated sustained favorable patient outcomes at six months in the TRISCEND study.

News | Structural Heart

Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients

November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve ...

November 08, 2021

The ControlRad device collimates the area of interest where the physicians are working, and reduces the dose significantly to peripheral areas in the image.

News | Radiation Dose Management

Beaumont Uses New Cardiac Cath Lab Technology to Reduce Radiation Exposure

November 5, 2021 – An FDA-approved device used during cardiac cath lab procedures cut radiation exposure for ...

November 05, 2021